Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors Seeking Recovery of the Lead Plaintiff Deadline on September 28, 2026 Ready to Announce with Confidence?
New York, New York--(Newsfile Corp. - August 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Capricor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than September 28, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
The complaint alleges that on July 27, 2026, before the market opened, the FDA released briefing documents ahead of its AdCom meeting for Capricor's resubmitted Dermamiocel Biologics License Application ("BLA"). Further, the complaint alleges that according to the briefing documents, Capricor made changes to the pre-specified statistical analysis plan ("SAP") and the final version "was not submitted to FDA for review prior to BLA submission and was not discussed and consequently not agreed upon." On July 27, 2026, Capricor's stock price fell $12.70, or 64%, to close at $7 per share.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
CONTACT:
Jeffrey P. Campisi
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(212) 329-8571
jcampisi@kaplanfox.com
Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1501
Oakland, California 94612
(415) 772-4704
lking@kaplanfox.com
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
https://www.kaplanfox.com/case/capricor-therapeutics-inc-investor-alert-learn-more-now/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308902
Source: Kaplan Fox & Kilsheimer LLP
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Kaplan Fox & Kilsheimer LLP or all companies in the Legal industry.
Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors Seeking Recovery of the Lead Plaintiff Deadline on September 28, 2026
2026-08-11 8:30 AM EDT
Kaplan Fox Alerts Investors of a Securities Class Action Against PROCEPT BioRobotics Corporation (PRCT) - Deadline is September 22, 2026
2026-08-11 8:15 AM EDT
Kaplan Fox Alerts Cogent Communications Holdings, Inc. (CCOI) Investors to a Securities Class Action Lawsuit - Contact the Firm Before Deadline on September 21, 2026 for Leadership Role
2026-08-11 8:00 AM EDT
Jun 30, 2026
Disclosure Intelligence Series How disclosure works in modern capital markets When a press release is distributed, most issuer teams consider the communication complete. But in reality, this is the point at which another audience begins reading it. Search engines, AI models, financial data platforms, and brokerage systems start processing corporate announcements within seconds of publication. Before many investors read a press release, machines identify companies, extract key facts,...
Litigation and Regulation
Legal